Galenvs leads the way in precision development and scalable manufacturing of nanomaterials and DNA/RNA oligonucleotides for therapeutic and diagnostic applications. The company offers end-to-end services spanning proof-of-concept, in-vitro validation, pilot-scale production, and beyond.